Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
2012 ◽
Vol 68
(7)
◽
pp. 1049-1056
◽
2009 ◽
Vol 34
(5)
◽
pp. 585-594
◽
1988 ◽
Vol 43
(1)
◽
pp. 63-71
◽
1981 ◽
Vol 20
(1)
◽
pp. 27-33
◽
2010 ◽
Vol 5
(9)
◽
pp. 1588-1594
◽
2002 ◽
Vol 3
(4)
◽
pp. 247-254
◽
Keyword(s):
1980 ◽
Vol 13
(1)
◽
pp. 193-201
Keyword(s):
2006 ◽
Vol 5
(1)
◽
pp. 105-105
Keyword(s):